Cross-country inequalities in disease burden and care quality of chronic kidney disease due to type 2 diabetes mellitus, 1990-2021: Findings from the global burden of disease study 2021
- PMID: 39344843
- DOI: 10.1111/dom.15969
Cross-country inequalities in disease burden and care quality of chronic kidney disease due to type 2 diabetes mellitus, 1990-2021: Findings from the global burden of disease study 2021
Abstract
Aim: To explore the trend of burden and care quality of chronic kidney disease due to type 2 diabetes mellitus (CKD-T2DM) and their cross-country inequalities from 1990 to 2021.
Materials and methods: Data were from the Global Burden of Disease 2021 study. Disease burden and care quality were quantified using the disability-adjusted life years rate and the quality-of-care index (QCI). Trend analyses of the age-standardized disability-adjusted life years rate (ASDR) and age-standardized QCI from 1990 to 2021 were conducted using the estimated annual percentage change. The associations of disease burden and care quality with the socio-demographic index (SDI) were explored. Cross-country inequalities in disease burden and care quality were assessed using the slope index of inequality (SII) and concentration index.
Results: From 1990 to 2021, the global ASDR for CKD-T2DM increased, while the age-standardized QCI slightly decreased, with an estimated annual percentage change of 0.81 [95% confidence interval (CI): 0.75, 0.87] and -0.08 (95% CI: -0.09, -0.07). The ASDR escalated with increasing SDI, reaching a peak at mid-level SDI, followed by a decrease. The age-standardized QCI was higher with increasing SDI. Globally, ASDR concentrated on countries/territories with a lower SDI. The SII of ASDR was -96.64 (95% CI: -136.94, -56.35) in 1990 and -118.15 (95% CI: -166.36, -69.94) in 2021, with a concentration index of -0.1298 (95% CI: -0.1904, -0.0692) in 1990 and -0.1104 (95% CI: -0.1819, -0.0389) in 2021. In 1990 and 2021, countries/territories at higher SDI levels exhibited increased age-standardized QCI, indicated by an SII of 15.09 (95% CI: 10.74, 19.45) and 15.75 (95% CI: 10.92, 20.59), and a concentration index of 0.0393 (95% CI: 0.0283, 0.0503) and 0.0400 (95% CI: 0.0264, 0.0536).
Conclusions: Our study highlights considerable disparities in the burden and care quality of CKD-T2DM. Regions experiencing an increasing burden and a declining care quality simultaneously underscore the need for further research and tailored health interventions.
Keywords: chronic kidney disease because of type 2 diabetes mellitus; disability‐adjusted life years; global burden of disease; inequality; quality of care.
© 2024 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Similar articles
-
Cross-country inequalities in the epidemiology of chronic kidney disease due to type 2 diabetes mellitus, 1990-2021: findings from the global burden of disease study 2021.Diabetol Metab Syndr. 2025 Jun 23;17(1):240. doi: 10.1186/s13098-025-01824-3. Diabetol Metab Syndr. 2025. PMID: 40551147 Free PMC article.
-
Trends and inequalities in gastrointestinal cancer care quality from 1990 to 2021: A population-based analysis of the Global Burden of Disease Study 2021.Medicine (Baltimore). 2025 Aug 1;104(31):e43569. doi: 10.1097/MD.0000000000043569. Medicine (Baltimore). 2025. PMID: 40760526 Free PMC article.
-
Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: A systematic analysis of Global Burden of Disease Study 2021.Chin Med J (Engl). 2025 Mar 5;138(5):568-578. doi: 10.1097/CM9.0000000000003428. Epub 2025 Jan 24. Chin Med J (Engl). 2025. PMID: 39863522 Free PMC article.
-
The global burden of adverse effects of medical treatment: a 30-year socio-demographic and geographic analysis using GBD 2021 data.Front Big Data. 2025 Aug 1;8:1590551. doi: 10.3389/fdata.2025.1590551. eCollection 2025. Front Big Data. 2025. PMID: 40821361 Free PMC article. Review.
-
Inequities in Pediatric Nephrology: Disparities in Children's Kidney Health and Access to Care.Adv Kidney Dis Health. 2025 May;32(3):266-278. doi: 10.1053/j.akdh.2025.01.001. Adv Kidney Dis Health. 2025. PMID: 40818892 Review.
Cited by
-
Joint association of the newly proposed dietary index for gut microbiota and sleep disorders with survival among US adult population with diabetes and pre-diabetes.Nutr J. 2025 Jun 18;24(1):95. doi: 10.1186/s12937-025-01162-0. Nutr J. 2025. PMID: 40533747 Free PMC article.
-
Exploring the role of NLRP3 infalmmasome in diabetes: a literature review and bibliometric analysis.Front Endocrinol (Lausanne). 2024 Dec 9;15:1443798. doi: 10.3389/fendo.2024.1443798. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39717099 Free PMC article. Review.
-
Identification of metabolic reprogramming-related genes as potential diagnostic biomarkers for diabetic nephropathy based on bioinformatics.Diabetol Metab Syndr. 2024 Nov 28;16(1):287. doi: 10.1186/s13098-024-01531-5. Diabetol Metab Syndr. 2024. PMID: 39609849 Free PMC article.
-
Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses.Front Public Health. 2025 Jun 11;13:1595159. doi: 10.3389/fpubh.2025.1595159. eCollection 2025. Front Public Health. 2025. PMID: 40567976 Free PMC article.
-
Health inequality and the global burden of mesothelioma: insights from the global burden of disease study 2021.BMC Cancer. 2025 Jul 16;25(1):1179. doi: 10.1186/s12885-025-14590-2. BMC Cancer. 2025. PMID: 40670971 Free PMC article.
References
REFERENCES
-
- Zhang XX, Kong J, Yun K. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: A meta‐analysis of observational studies. J Diabetes Res. 2020;2020:2315607. doi:10.1155/2020/2315607
-
- Xie Y, Bowe B, Mokdad AH, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567‐581. doi:10.1016/j.kint.2018.04.011
-
- Woo KT, Choong HL, Wong KS, Tan HB, Chan CM. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2012;81(10):1044‐1045. doi:10.1038/ki.2012.39
-
- Evaluation IfHMa. Global Burden of Disease (GBD). https://vizhub.healthdata.org/gbd-compare/
-
- Ruiz‐Ortega M, Rodrigues‐Diez RR, Lavoz C, Rayego‐Mateos S. Special issue “Diabetic nephropathy: diagnosis, prevention and treatment”. J Clin Med. 2020;9(3):813. doi:10.3390/jcm9030813
MeSH terms
LinkOut - more resources
Full Text Sources
Medical